Latest News about Analyst Color
Recent news which mentions Analyst Color
Axsome's Solriamfetol Fails Primary Goal In Depression Study But Shows Improvements In Associated Sleep Disorder
April 01, 2025
From Benzinga
Veteran Investor Warns Of Rising Stagflation Risk As Tariffs Loom, Anticipates 'Squeezed Profit Margins' For US Businesses
April 01, 2025
From Benzinga
US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert
April 01, 2025
From Benzinga
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
March 31, 2025
From Benzinga
Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast
March 31, 2025
From Benzinga
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
March 31, 2025
From Benzinga
Gold Rally Could Gain Momentum With Central Bank Buying And China Allocation, Analyst Says
March 31, 2025
From Benzinga
From Benzinga
CAVA Can Outgrow Expectations With Strong Unit Economics And Market Headroom, Analyst Says
March 31, 2025
From Benzinga
CoreWeave IPO Performance Likely Due To Company, Not AI Sector: Analyst Says 'Investor Sentiment Remains Mixed'
March 31, 2025
From Benzinga
Tariff Turmoil: Cleveland-Cliffs, Constellium, Freeport-McMoRan Caught In The Crossfire, Says Analyst
March 31, 2025
From Benzinga
Noble Q1 Earnings Preview: Analyst Cuts Forecast On Idle Capacity, 2025 Guidance 'Remains Within Striking Distance'
March 31, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
